Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Pulmonary Hypertension

  Free Subscription


30.01.2017

1 Am J Cardiovasc Drugs
1 Am J Hematol
2 Am J Respir Cell Mol Biol
1 Ann Hematol
1 Ann Thorac Surg
1 Arch Cardiovasc Dis
2 Arch Dis Child Fetal Neonatal Ed
1 Biol Pharm Bull
1 BMC Pulm Med
1 Cardiovasc Res
1 Cell Prolif
1 Chin Med J (Engl)
1 Cleve Clin J Med
2 Dis Mon
1 Eur J Radiol
1 Gene
1 Haematologica
1 Int J Cardiovasc Imaging
1 Int Ophthalmol
1 J Am Soc Hypertens
1 J Card Fail
1 J Dermatol
1 Pediatr Emerg Care
1 Pharmacoeconomics
1 Pneumonol Alergol Pol
1 Postgrad Med
1 Radiographics
1 Rev Port Cardiol
1 Scand J Rheumatol
1 Zhonghua Jie He He Hu Xi Za Zhi


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Cardiovasc Drugs

  1. DUGGAN ST, Keam SJ, Burness CB
    Selexipag: A Review in Pulmonary Arterial Hypertension.
    Am J Cardiovasc Drugs. 2017;17:73-80.
    PubMed     Text format     Abstract available


    Am J Hematol

  2. SCIUME M, Mattiello V, Cattaneo D, Bucelli C, et al
    Early Detection of Pulmonary Hypertension in Primary Myelofibrosis: The role of Echocardiography, Cardiopulmonary Exercise Testing and Biomarkers.
    Am J Hematol. 2017 Jan 21. doi: 10.1002/ajh.24656.
    PubMed     Text format    


    Am J Respir Cell Mol Biol

  3. AMSELLEM V, Abid S, Poupel L, Parpaleix A, et al
    Roles for the CX3CL1/CX3CR1 and CCL2/CCR2 Chemokine Systems in Hypoxic Pulmonary Hypertension.
    Am J Respir Cell Mol Biol. 2017 Jan 26. doi: 10.1165/rcmb.2016-0201.
    PubMed     Text format     Abstract available

  4. MENG Q, Lai YC, Kelly NJ, Bueno M, et al
    Development of a Mouse Model of Metabolic Syndrome, Pulmonary Hypertension, and Heart Failure with Preserved Ejection Fraction (PH-HFpEF).
    Am J Respir Cell Mol Biol. 2017 Jan 24. doi: 10.1165/rcmb.2016-0177.
    PubMed     Text format     Abstract available


    Ann Hematol

  5. MATTAR MM, Morad MA, El Husseiny NM, Ali NH, et al
    Correlation between JAK2 allele burden and pulmonary arterial hypertension and hematological parameters in Philadelphia negative JAK2 positive myeloproliferative neoplasms. An Egyptian experience.
    Ann Hematol. 2016;95:1611-6.
    PubMed     Text format     Abstract available


    Ann Thorac Surg

  6. LOUP O, Wustmann K, Martinelli MV, Schwerzmann M, et al
    Failing Systemic Right Ventricles With Persistent Pulmonary Hypertension: Candidates for Ventricular Assist Devices as Destination Therapy?
    Ann Thorac Surg. 2017;103:e179-e181.
    PubMed     Text format     Abstract available


    Arch Cardiovasc Dis

  7. VOILLIOT D, Magne J, Dulgheru R, Kou S, et al
    Prediction of new onset of resting pulmonary arterial hypertension in systemic sclerosis.
    Arch Cardiovasc Dis. 2016;109:268-77.
    PubMed     Text format     Abstract available


    Arch Dis Child Fetal Neonatal Ed

  8. STENSON B
    Highlights from this issue.
    Arch Dis Child Fetal Neonatal Ed. 2016;101:F279.
    PubMed     Text format    

  9. GIEN J, Kinsella JP
    Differences in preductal and postductal arterial blood gas measurements in infants with severe congenital diaphragmatic hernia.
    Arch Dis Child Fetal Neonatal Ed. 2016;101:F314-8.
    PubMed     Text format     Abstract available


    Biol Pharm Bull

  10. NOSE T, Kondo M, Shimizu M, Hamura H, et al
    Pharmacological Profile of GPD-1116, an Inhibitor of Phosphodiesterase 4.
    Biol Pharm Bull. 2016;39:689-98.
    PubMed     Text format     Abstract available


    BMC Pulm Med

  11. GUILLEMINAULT L, Laurent S, Foucher A, Poubeau P, et al
    Pulmonary arterial hypertension in adult onset Still's disease: a case report of a severe complication.
    BMC Pulm Med. 2016;16:72.
    PubMed     Text format     Abstract available


    Cardiovasc Res

  12. WANG X, Ibrahim YF, Das D, Zungu-Edmondson M, et al
    Carfilzomib reverses pulmonary arterial hypertension.
    Cardiovasc Res. 2016;110:188-99.
    PubMed     Text format     Abstract available


    Cell Prolif

  13. WANG P, Xu J, Hou Z, Wang F, et al
    miRNA-34a promotes proliferation of human pulmonary artery smooth muscle cells by targeting PDGFRA.
    Cell Prolif. 2016;49:484-93.
    PubMed     Text format     Abstract available


    Chin Med J (Engl)

  14. HE WX, Yang YL, Xia Y, Song N, et al
    Outcomes of Chinese Patients with End-stage Pulmonary Disease while Awaiting Lung Transplantation: A Single-center Study.
    Chin Med J (Engl). 2016;129:3-7.
    PubMed     Text format     Abstract available


    Cleve Clin J Med

  15. AHMED M, Dweik RA, Tonelli AR
    What is the best approach to a high systolic pulmonary artery pressure on echocardiography?
    Cleve Clin J Med. 2016;83:256-60.
    PubMed     Text format    


    Dis Mon

  16. ATAYA A, Patel S, Cope J, Alnuaimat H, et al
    Pulmonary arterial hypertension and associated conditions.
    Dis Mon. 2016;62:379-402.
    PubMed     Text format    

  17. LEIKIN JB
    Foreword.
    Dis Mon. 2016;62:378.
    PubMed     Text format    


    Eur J Radiol

  18. TASLAKIAN B, Latson LA, Truong MT, Aaltonen E, et al
    CT pulmonary angiography of adult pulmonary vascular diseases: Technical considerations and interpretive pitfalls.
    Eur J Radiol. 2016;85:2049-2063.
    PubMed     Text format     Abstract available


    Gene

  19. ALI Z, Waseem M, Kumar R, Pandey P, et al
    Unveiling the interactions among BMPR-2, ALK-1 and 5-HTT genes in the pathophysiology of HAPE.
    Gene. 2016;588:163-72.
    PubMed     Text format     Abstract available


    Haematologica

  20. WEIR NA, Saiyed R, Alam S, Conrey A, et al
    Prostacyclin-analog therapy in sickle cell pulmonary hypertension.
    Haematologica. 2017 Jan 25. pii: haematol.2015.131227.
    PubMed     Text format     Abstract available


    Int J Cardiovasc Imaging

  21. AMSALLEM M, Boulate D, Kooreman Z, Zamanian RT, et al
    Investigating the value of right heart echocardiographic metrics for detection of pulmonary hypertension in patients with advanced lung disease.
    Int J Cardiovasc Imaging. 2017 Jan 24. doi: 10.1007/s10554-017-1069.
    PubMed     Text format     Abstract available


    Int Ophthalmol

  22. FENG Z, Dong L, Cao J, Bai J, et al
    A case study of ciliary detachment with primary pulmonary hypertension.
    Int Ophthalmol. 2017 Jan 21. doi: 10.1007/s10792-017-0443.
    PubMed     Text format     Abstract available


    J Am Soc Hypertens

  23. WU J, Jia J, Liu L, Yang F, et al
    Schisandrin B displays a protective role against primary pulmonary hypertension by targeting transforming growth factor beta1.
    J Am Soc Hypertens. 2016 Dec 28. pii: S1933-1711(16)30606.
    PubMed     Text format     Abstract available


    J Card Fail

  24. ZOLTY R
    Pulmonary Hypertension in Left Ventricular Dysfunction: Still Numerous Unanswered Questions.
    J Card Fail. 2017 Jan 23. pii: S1071-9164(17)30030.
    PubMed     Text format    


    J Dermatol

  25. HASEGAWA M
    Biomarkers in systemic sclerosis: Their potential to predict clinical courses.
    J Dermatol. 2016;43:29-38.
    PubMed     Text format     Abstract available


    Pediatr Emerg Care

  26. TANEL RE
    ECGs in the ED.
    Pediatr Emerg Care. 2016;32:202-3.
    PubMed     Text format    


    Pharmacoeconomics

  27. COYLE K, Coyle D, Blouin J, Lee K, et al
    Cost Effectiveness of First-Line Oral Therapies for Pulmonary Arterial Hypertension: A Modelling Study.
    Pharmacoeconomics. 2016;34:509-20.
    PubMed     Text format     Abstract available


    Pneumonol Alergol Pol

  28. SAHNI S, Ojrzanowski M, Majewski S, Talwar A, et al
    Pulmonary arterial hypertension: a current review of pharmacological management.
    Pneumonol Alergol Pol. 2016;84:47-61.
    PubMed     Text format     Abstract available


    Postgrad Med

  29. VELAYATI A, Valerio MG, Shen M, Tariq S, et al
    Update on pulmonary arterial hypertension pharmacotherapy.
    Postgrad Med. 2016;128:460-73.
    PubMed     Text format     Abstract available


    Radiographics

  30. BAXI AJ, Restrepo CS, Vargas D, Marmol-Velez A, et al
    Hypertrophic Cardiomyopathy from A to Z: Genetics, Pathophysiology, Imaging, and Management.
    Radiographics. 2016;36:335-54.
    PubMed     Text format     Abstract available


    Rev Port Cardiol

  31. PLACIDO R, Cortez-Dias N, Robalo Martins S, Gomes Almeida A, et al
    Prognostic stratification in pulmonary hypertension: A multi-biomarker approach.
    Rev Port Cardiol. 2017 Jan 21. pii: S0870-2551(16)30215.
    PubMed     Text format     Abstract available


    Scand J Rheumatol

  32. DELLA ROSSA A, D'Ascanio A, Barsotti S, Stagnaro C, et al
    Post-occlusive reactive hyperaemia (POHR) in systemic sclerosis: very early disease (VEDOSS) represents a separate entity compared to established disease.
    Scand J Rheumatol. 2016;45:408-11.
    PubMed     Text format     Abstract available


    Zhonghua Jie He He Hu Xi Za Zhi

  33. SUN M, Li HX, Xie YF, Xu H, et al
    [Outcomes after singleversus bilateral lung transplantation for idiopathic pulmonary fibrosis].
    Zhonghua Jie He He Hu Xi Za Zhi. 2016;39:444-9.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: